This page shows the latest omalizumab news and features for those working in and with pharma, biotech and healthcare.
The FDA has approved the biologics licence application (BLA) for Xolair(omalizumab) prefilled syringe for self-injection across all approved indications in the US.
older immunology drug Xolair (omalizumab). .
The key drugs which have been added to the list include AbbVie’s blockbuster drug Humira (adalimumab), Novartis’ dermatitis drug Xolair (omalizumab) and Roche’s HER2 breast cancer treatment Perjeta (petuzumab).
Roche and Novartis’ severe asthma therapy Xolair (omalizumab) has data showing it is effective as a treatment for polyps, but isn’t expected to be approved until the end of next
The firm has recently picked up Chinese approvals for a clutch of therapies including Xolair (omalizumab) for asthma and heart failure therapy Entresto (valsartan/sacubitril).
The US regulator awarded Xolair (omalizumab) the coveted status for the prevention of severe allergic reactions following accidental exposure to one or more foods in people with allergies, opening up another
More from news
Approximately 7 fully matching, plus 22 partially matching documents found.
A meta-analysis of real-world studies where omalizumab treatment of chronic idiopathic urticaria met or improved on both efficacy and safety predictions from the RCTs.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...